Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chloroquine ‘Approval’ For COVID-19 And The US FDA’s New Reality

Apr 01 2020

• By Michael McCaughan

Los Angeles, CA / USA - March 25, 2020: A White House mailer from March 16 reads: “SLOW THE SPREAD. PRESIDENT TRUMP’S CORONAVIRUS GUIDELINES FOR AMERICA," with tips for avoiding COVID-19 on the back.

Related Content

US FDA Commissioner Hahn’s Star Turn: Baptism By Fire Turns Perilous

Mar 29 2020

FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments

Mar 31 2020

Off-Label Promoter In Chief: President Trump Pushes COVID-19 Therapy

Mar 24 2020

Additional Topics

United States Coronavirus COVID-19 Leadership Politics Approvals FDA Regulation BioPharmaceutical Infectious Diseases

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window